Sanford C. Bernstein’s He on China Healthcare, Drug Prices

The video discusses China's healthcare system, focusing on the challenges posed by an aging population and high cancer rates. It highlights government reforms aimed at reducing drug prices and shifting focus from older drugs to innovative new ones. The impact of these reforms on domestic and foreign companies is explored, along with strategies for companies to adapt. The video concludes with a look at future opportunities in the healthcare sector, emphasizing the importance of innovation and ecosystem collaboration.

What are the expected outcomes of the updated national reimbursement drug list in China?

How do innovative drug companies benefit from the changes in the Chinese healthcare system?

What factors contribute to the high drug prices in China compared to other countries?